Richard Robinson
Psychiatric/Mental Health · Hoover, ALNPI 1336673656
Payments from drug & device makers
Across 160 payments — averaging $21.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$752
- Otsuka America Pharmaceutical, Inc.$468
- Johnson & Johnson$406
- Teva Pharmaceuticals USA, Inc.$327
- Lundbeck LLC$290
- Axsome Therapeutics, Inc.$220
- plus $934 from 12 others
What the payments were for
- Food & beverage$3,396100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 35 | $752 |
| Otsuka America Pharmaceutical, Inc. | 19 | $468 |
| Johnson & Johnson | 18 | $406 |
| Teva Pharmaceuticals USA, Inc. | 18 | $327 |
| Lundbeck LLC | 11 | $290 |
| Axsome Therapeutics, Inc. | 9 | $220 |
| AbbVie | 18 | $207 |
| Vanda Pharmaceuticals Inc. | 6 | $185 |
| Neurocrine Biosciences, Inc. | 7 | $174 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $125 |
| Tris Pharma Inc | 3 | $59 |
| Alkermes, Inc. | 2 | $49 |
| Corium, LLC | 2 | $47 |
| Almatica Pharma LLC | 1 | $21 |
| Acadia Pharmaceuticals Inc | 1 | $20 |
| Neos Therapeutics, LP | 1 | $18 |
| Ironshore Pharmaceuticals Inc. | 1 | $16 |
| Noven Therapeutics, LLC | 1 | $14 |
How this compares
$3,396 in reported general payments places this provider in the 70th percentile of 378 psychiatric/mental health providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 13 | $1,131 |
| Bupropion XlBupropion Hcl | 11 | $241 |
| Trazodone Hcl | 12 | $155 |
| Lamotrigine | 14 | $154 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Hoover
- Logan ThrasherHoover$22K
- Latisha AliHoover$15K
- Laura GrahamMontgomery$80K
- Yuliya SpencerBirmingham$65K
- Keri BarrBay Minette$35K
- John HayesMobile$30K
- Anthony PhillipsHelena$15K
- Ian KinzerHuntsville$15K
- Taylor BarrettGadsden$15K
- Angela GarrardGadsden$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.